Nov. 4, 2025

IR

Notice Concerning Share of Loss of Investments Accounted for Using the Equity Method and Finance Income (Foreign Exchange Gain)

Nov. 4, 2025

IR

Sumitomo Chemical Announces Variances between its Financial Forecast and Actual Results for the Second Quarter (Interim Period) of the Full Year Ending March 31, 2026, and Revisions to its Financial Forecast for the Full Year Ending March 31, 2026

Nov. 4, 2025

IR

Summary of Consolidated Financial Results for Second Quarter (Interim Period) Fiscal Year 2025

Oct. 31, 2025

IR

Integrated Report 2025 and Sustainabillity Report 2025 have been published

Oct. 28, 2025

IR

Notice Regarding Execution of a Share Exchange Agreement (Simplified Share Exchange) to Make Tanaka Chemical Corporation a Wholly-Owned Subsidiary of Sumitomo Chemical Co., Ltd.

Oct. 22, 2025

IR

(Progress of Disclosure Matters) Notice Regarding the Impact on Results of Sale and Other Transactions of Shares in Petro Rabigh, an Equity-Method Affiliate

Sep. 26, 2025

IR

"Investors' Meeting for the Current Priority Management Issues and Business Strategy" has been released.

Sep. 1, 2025

Announcements

Investors' Handbook 2025 has been published

Sep. 1, 2025

IR

(Progress of Disclosure Matters) Notice Regarding Sale of a Portion of the Shares Sumitomo Chemical Holds in Petro Rabigh and Other Related Matters

Aug. 5, 2025

IR

Announcement of a Subsidiary's Submission of the Application of Manufacturing and Marketing Authorization for an iPS Cell-Derived Product for Parkinson's Disease in Japan

Aug. 1, 2025

IR

Sumitomo Chemical Reports Unrealized Losses on Securities as of June 30, 2025

Aug. 1, 2025

IR

Notice Concerning Finance Expenses (Foreign Exchange Loss)

Aug. 1, 2025

IR

Summary of Consolidated Financial Results for First Quarter Fiscal Year 2025

Jul. 31, 2025

IR

(Progress of Disclosure Matters) Notice Regarding Completion of Procedures for a Company Split (Simplified Absorption-Type Company Split) by a Subsidiary

Jul. 18, 2025

IR

Notice Regarding Payment Completed of New Shares as Restricted Stock Compensation

Jun. 20, 2025

IR

Notice Regarding Issuance of New Shares as Restricted Stock Compensation

May. 22, 2025

Announcements

Notice of the 144th Ordinary General Meeting of Shareholders has been published.

May. 14, 2025

IR

Summary of Consolidated Financial Results for Fiscal Year 2024

May. 14, 2025

IR

Notice Concerning Impairment Loss and Finance Expenses (Foreign Exchange Loss)

May. 14, 2025

Organization

Notice Regarding Changes in Representative Director